DEPUY ASR XL FEM IMP SIZE 47
Report
- Report Number
- 1818910-2011-05276
- Event Type
- Injury
- Date Received
- May 18, 2011
- Date of Event
- March 18, 2011
- Report Date
- May 12, 2014
- Manufacturer
- DEPUY INTERNATIONAL, LTD.
- Product Code
- KWA
- PMA / PMN Number
- NA
- Removal / Correction Number
- Z-1790-2011
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
Narratives
NO 510K# SUBMITTED AS DEPUY ORTHOPAEDICS SELLS A SIMILAR PRODUCT (OR THE SAME PRODUCT WITH A DIFFERENT PRODUCT CODE) IN THE U.S. THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.
THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4).
DEPUY STILL CONSIDERS THE INVESTIGATION CLOSED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.
SURGICAL INTERVENTION DUE TO ASR RECALL.
NEW ETQ RECORD CREATED IN ORDER TO UPDATE ETQ (LEGACY SYSTEM) COMPLAINT NUMBER (B)(4). REASON FOR ORIGINAL COMPLAINT - ASR. CLAIMSUITE REF: (B)(4). ASR XL ACETABULAR SYSTEM (RIGHT); REASON(S) FOR REVISION: NOISE. COMMENTS RECEIVED FROM (B)(6) 11TH AUG 2011 - "THE OPERATION I HAVE REPORTED AS THE FIRST REVISION (DATE (B)(6) 2010) IS TECHNICALLY NOT A REVISION. THE IMPLANT WERE NOT REPLACED (B)(6) 2010. THE SECOND OPERATION (DATE (B)(6) 2011), THE TECHNICALLY REVISION WERE THE IMPLANT IS REPLACED." UPDATE RECEIVED: 12TH MAY 2014 - ADDED FURTHER REASON(S) FOR REVISION: PAIN AND METALLOSIS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | DEPUY ASR XL FEM IMP SIZE 47 | HIP FEMORAL HEAD | KWA | DEPUY INTERNATIONAL, LTD. | NA | 2445350 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 59 YR | Required Intervention |